Cell therapy for active crohn's disease
Part of Digestive system clinical trials.
This trial tests an experimental cell therapy called ATORM-C for people with Crohn's disease who haven't gotten better with standard treatments. The goal is to see if this new treatment can help heal the intestinal ulcers that cause symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 79 years old.
- You need a Crohn's disease diagnosis for at least 6 months, confirmed by tests.
- You must have tried standard Crohn's treatments for 6 months without enough improvement.
- You need active symptoms like frequent loose stools or belly pain.
- A colonoscopy must show active ulcers, with at least one ulcer 5 mm or larger.
- You must be in generally good health, without serious infections, cancer history, or uncontrolled medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether an “autologous” stem cell transplant (using your own cells) can improve Crohn’s disease that has not responded to standard treatments. It may help people who have ongoing, hard-to-control Crohn’s even after medicines and/or who have complications that make surgery risky.
This trial is testing a new investigational treatment called TRX103 for adults with moderate to severe Crohn's disease that has not responded to at least two other advanced therapies. The study aims to see if this treatment can reduce inflammation and improve symptoms.
This trial tests a new cell injection (TH-SC01) to treat anal fistulas caused by Crohn's disease. It aims to see if the injection can heal fistulas and lower infection risk.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
This Phase 2 study tests whether a transplant using your own stem cells can calm active Crohn’s disease that hasn’t improved with standard medicines. It may help some people with ongoing inflammation and symptoms after multiple Crohn’s treatments.
This trial tests whether a stem cell transplant from a partially matched family member or unrelated donor can help people with severe, hard-to-treat Crohn disease, especially when it starts early or has a known genetic cause. The transplant aims to replace the immune system to stop the disease from attacking the gut.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.